Literature DB >> 20304011

Influenza virus-like particles as an antigen-carrier platform for the ESAT-6 epitope of Mycobacterium tuberculosis.

Florian Krammer1, Theresa Schinko, Paul Messner, Dieter Palmberger, Boris Ferko, Reingard Grabherr.   

Abstract

Various virus-like particles (VLPs) have been shown to induce cytotoxic T-cell immune response as well as B-cell immune response. This makes VLPs promising candidates for antigen-carrier platforms for various epitopes. Influenza A VLPs were produced displaying a 20 amino acid sequence from Mycobacterium tuberculosis early secretory antigenic target 6 protein (ESAT-6). As this sequence is known to comprise a potent T-cell epitope it was chosen as a model for a foreign epitope to be presented on an influenza VLP scaffold. The ESAT-6 epitope was engineered into the antigenic region B of the influenza hemagglutinin (HA) from strain A/New Caledonia/20/99. VLPs were expressed in insect cells and subjected to immunization studies in mice. High serum antibody titers detected against recombinant ESAT-6 demonstrated the feasibility of influenza A VLPs serving as an efficient platform for epitope presentation. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20304011      PMCID: PMC4388402          DOI: 10.1016/j.jviromet.2010.03.003

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  64 in total

1.  Virus-like particles as carriers for T-cell epitopes: limited inhibition of T-cell priming by carrier-specific antibodies.

Authors:  Christiane Ruedl; Katrin Schwarz; Andrea Jegerlehner; Tazio Storni; Vania Manolova; Martin F Bachmann
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 2.  A new generation of protein display scaffolds for molecular recognition.

Authors:  Ralf J Hosse; Achim Rothe; Barbara E Power
Journal:  Protein Sci       Date:  2006-01       Impact factor: 6.725

Review 3.  From the first to the third generation adenoviral vector: what parameters are governing the production yield?

Authors:  E Dormond; M Perrier; A Kamen
Journal:  Biotechnol Adv       Date:  2008-10-31       Impact factor: 14.227

4.  Baculovirus surface display: construction and screening of a eukaryotic epitope library.

Authors:  W Ernst; R Grabherr; D Wegner; N Borth; A Grassauer; H Katinger
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

5.  Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells.

Authors:  C Sedlik; M Saron; J Sarraseca; I Casal; C Leclerc
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Established insect cell line from the cabbage looper, Trichoplusia ni.

Authors:  W F Hink
Journal:  Nature       Date:  1970-05-02       Impact factor: 49.962

Review 8.  Influenza vaccines based on virus-like particles.

Authors:  Sang-Moo Kang; Jae-Min Song; Fu-Shi Quan; Richard W Compans
Journal:  Virus Res       Date:  2009-04-15       Impact factor: 3.303

9.  Swine-origin pandemic H1N1 influenza virus-like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice.

Authors:  Florian Krammer; Sabine Nakowitsch; Paul Messner; Dieter Palmberger; Boris Ferko; Reingard Grabherr
Journal:  Biotechnol J       Date:  2010-01       Impact factor: 4.677

10.  Expression and purification of an influenza hemagglutinin--one step closer to a recombinant protein-based influenza vaccine.

Authors:  Keyang Wang; Kathleen M Holtz; Karl Anderson; Richard Chubet; Wafaa Mahmoud; Manon M J Cox
Journal:  Vaccine       Date:  2005-11-10       Impact factor: 3.641

View more
  5 in total

1.  Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein.

Authors:  Jia Lu; Chun Wang; Zhiguang Zhou; Ying Zhang; Tingting Cao; Chunwei Shi; Zhenhua Chen; Lingxia Chen; Changxue Cai; Xionglin Fan
Journal:  Clin Dev Immunol       Date:  2011-02-27

2.  Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.

Authors:  Miriam Klausberger; Rupert Tscheliessnig; Silke Neff; Raffael Nachbagauer; Teddy John Wohlbold; Monika Wilde; Dieter Palmberger; Florian Krammer; Alois Jungbauer; Reingard Grabherr
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

Review 3.  Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: Benefits and drawbacks.

Authors:  Stanislav Sokolenko; Steve George; Andreas Wagner; Anup Tuladhar; Jonas M S Andrich; Marc G Aucoin
Journal:  Biotechnol Adv       Date:  2012-01-28       Impact factor: 14.227

Review 4.  Use of baculovirus expression system for generation of virus-like particles: successes and challenges.

Authors:  Fuxiao Liu; Xiaodong Wu; Lin Li; Zengshan Liu; Zhiliang Wang
Journal:  Protein Expr Purif       Date:  2013-06-03       Impact factor: 1.650

5.  An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.

Authors:  Dhiraj Acharya; Fengwei Bai
Journal:  Methods Mol Biol       Date:  2016
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.